Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
K. Shean, M. Badri, L. Page-Shipp, S. Siwendu, A. Burns, C. Kvasnovsky, J. Jurand, M. Loveday, P. Willcox, A. Zumla, M. Grobusch, M. van der Walt, K. Dheda (Cape Town, Pretoria, Johannesburg, Durban, South Africa; London, United Kingdom; Calgary, Canada). South African patients with extensively drug-resistant tuberculosis have poor outcomes regardless of HIV status. Eur Respir J 2009; 34: Suppl. 53, 4449

Member's Comments

No comment yet.

Related content which might interest you: Long-term bedaquiline-related treatment outcomes in patients with extensively drug-resistant tuberculosis from South Africa Source: Eur Respir J, 51 (5) 1800544; 10.1183/13993003.00544-2018 Year: 2018 Treatment outcomes among childhood extensively drug-resistant tuberculosis patients in Pakistan Source: ERJ Open Res, 8 (1) 00551-2021; 10.1183/23120541.00551-2021 Year: 2022 Clinical outcomes of patients with drug-resistant and extensively drug-resistant tuberculosis in Europe Source: Annual Congress 2008 - Priorities for tuberculosis research in Europe: discussing the results of the Tuberculosis Network European Trials Group (TBNET) Year: 2008 Treatment outcomes of MDR-TB and HIV co-infection in Europe Source: Eur Respir J, 49 (6) 1602363; 10.1183/13993003.02363-2016 Year: 2017 The risk factors of latent tuberculosis infection among health care workers in South Korea, an intermediate tuberculosis burden country Source: International Congress 2018 – Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity Year: 2018 TB drug resistance in high-incidence countries Source: Eur Respir Mon 2012; 58: 95-110 Year: 2012 Trilateral overlap of tuberculosis, diabetes and HIV-1 in a high-burden African setting: implications for TB control Source: Eur Respir J, 50 (1) 1700004; 10.1183/13993003.00004-2017 Year: 2017 Incidence of occupational latent tuberculosis infection in South African healthcare workers Source: Eur Respir J 2015; 45: 1364-1373 Year: 2015 Latent tuberculosis among adult children of immigrant parents from countries with a high incidence of tuberculosis compared to adult children of parents from countries with a low incidence of tuberculosis. Source: International Congress 2019 – Paediatric tuberculosis Year: 2019 Prevalence of urban vs rural HIV infection in patients of pulmonary tuberculosis: An Indian scenario Source: Annual Congress 2010 - Clinical tuberculosis Year: 2010 Traditional healers, treatment delay, performance status and death from tuberculosis in rural South Africa Source: Eur Respir J 2005; 26: Suppl. 49, 428s Year: 2005 High prevalence of hepatitis C among patients with drug-resistant tuberculosis and its impact on the treatment outcome in Azerbaijan prisons Source: International Congress 2015 – Screening strategies in TB Year: 2015 Assessing the risk of tuberculosis infection in a vulnerable population group (ethnicity rrome) in a TB endemic population Source: Annual Congress 2011 - Tuberculosis epidemiology and public health Year: 2011 High tuberculosis burden among people living with HIV in southern Mozambique Source: Eur Respir J 2015; 45: 547-549 Year: 2015 High burden of prevalent tuberculosis among previously treated people in Southern Africa suggests potential for targeted control interventions Source: Eur Respir J 2016; 48: 1227-1230 Year: 2016 Prognosis and outcome in patients with extremely drug resistant tuberculosis from the Western Cape province, South Africa Source: Annual Congress 2008 - Outcomes of tuberculosis treatment Year: 2008 Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB Source: Eur Respir J 2009; 33: 1085-1094 Year: 2009 Multidrug-resistance tuberculosis and HIV-infected patients, the effectiveness of the treatment in Ukraine Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010 Impact of HIV status, CD4 count and antiretroviral treatment on tuberculosis treatment outcomes in a low-burden country Source: International Congress 2017 – TB: co-morbidities and outcome Year: 2017 Study of isoniazid-resistant tuberculosis including outcomes in a high prevalence area in London Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012